Journal article
Body-mass index and all-1 cause mortality: Individual-participant-data meta-analysis of 239 prospective studies in four continents
- Abstract:
- Background: Overweight and obesity are increasing worldwide. To help assess their relevance to mortality in different populations we conducted individual-participant-data meta-analyses of the prospective studies of body mass index (BMI), limiting confounding and reverse causality by restricting analyses to never-smokers and excluding prior disease and the first 5 years of follow- up. Methods: Of 10,625,411 participants in Asia, Australia/New Zealand, Europe, and North America from 239 prospective studies (median follow-up 13·7 [IQR: 11·4-14·7] years), 3,951,455 in 189 studies were never-smokers without specific chronic diseases at recruitment who survived 5 years, of whom 385,879 died. The primary analyses are of these deaths, using age and sex-adjusted hazard ratios (HRs). Findings: All-cause mortality was minimal (HR=1) at BMI (kg/m2) 20-25, and increased significantly both just below this range (BMI 18·5-<20: HR=1·13, 95%CI 1·09-1·17; BMI 15- <18·5: HR=1·51, 1·43-1·59) and throughout the overweight range just above it (BMI 25-<27·5: HR=1·07, 1·07-1·08; BMI 27·5-<30: HR=1·20, 1·18-1·22). Continuing upwards, HRs for obesity grade I, II, and III (BMI 30-<35, 35-<40, 40-<60) were 1·45 (1·41-1·48), 1·94 (1·87-2.01), and 2·76 (2·60-2·92), respectively. For BMI>25, mortality increased approximately log-linearly with BMI; HR per 5 units higher BMI was 1·31 (1·29-1·33) in all regions; 1·39 (1·35-1·43) in Europe; 1·29 (1·26-1·32) in North America, 1·39 (1·34-1·44) in East Asia, and 1.31 (1.27, 1.35) in Australia/New Zealand. This HR per 5 units higher BMI (for BMI>25) was greater in younger than older people (1.52 at 35–49 years vs 1·21 at 70-89 years; Pheterogeneity<0·0001), greater in men than women (1·51 vs 1·30; Pheterogeneity<0·0001), but similar in studies with self-reported and measured BMI. Interpretation: The associations of both overweight and obesity with higher all-cause mortality were broadly consistent in four continents. This supports strategies to combat the entire spectrum of excess adiposity in many populations.
- Publication status:
- Published
- Peer review status:
- Peer reviewed
Actions
Access Document
- Files:
-
-
(Preview, Version of record, pdf, 625.3KB, Terms of use)
-
- Publisher copy:
- 10.1016/S0140-6736(16)30175-1
Authors
- Publisher:
- Elsevier
- Journal:
- Lancet More from this journal
- Volume:
- 388
- Issue:
- 10046
- Pages:
- 776-786
- Publication date:
- 2016-07-13
- Acceptance date:
- 2016-04-01
- DOI:
- EISSN:
-
1474-547X
- ISSN:
-
0140-6736
- Pubs id:
-
pubs:616637
- UUID:
-
uuid:e5e3b775-c5c6-4c14-8b23-0fede9c743b6
- Local pid:
-
pubs:616637
- Source identifiers:
-
616637
- Deposit date:
-
2016-04-20
Terms of use
- Copyright holder:
- © 2016 The Author(s)
- Copyright date:
- 2016
- Notes:
- © 2016 The Author(s). Published by Elsevier Ltd. This paper has been published under a Creative Common CC BY 4.0 license, see: https://creativecommons.org/licenses/by/4.0/
- Licence:
- CC Attribution (CC BY)
If you are the owner of this record, you can report an update to it here: Report update to this record